169 related articles for article (PubMed ID: 37186040)
1. Development and Validation of the Negative Symptom Inventory-Psychosis Risk.
Strauss GP; Walker EF; Pelletier-Baldelli A; Carter NT; Ellman LM; Schiffman J; Luther L; James SH; Berglund AM; Gupta T; Ristanovic I; Mittal VA
Schizophr Bull; 2023 Sep; 49(5):1205-1216. PubMed ID: 37186040
[TBL] [Abstract][Full Text] [Related]
2. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
[TBL] [Abstract][Full Text] [Related]
3. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
[TBL] [Abstract][Full Text] [Related]
4. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
Strauss GP; Gold JM
Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
[TBL] [Abstract][Full Text] [Related]
5. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
[TBL] [Abstract][Full Text] [Related]
6. Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS).
Pelletier-Baldelli A; Strauss GP; Visser KH; Mittal VA
Schizophr Res; 2017 Nov; 189():43-49. PubMed ID: 28189529
[TBL] [Abstract][Full Text] [Related]
7. A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
Strauss GP; Pelletier-Baldelli A; Visser KF; Walker EF; Mittal VA
Schizophr Res; 2020 Aug; 222():104-112. PubMed ID: 32522469
[TBL] [Abstract][Full Text] [Related]
8. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
[TBL] [Abstract][Full Text] [Related]
9. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
Strauss GP; Keller WR; Buchanan RW; Gold JM; Fischer BA; McMahon RP; Catalano LT; Culbreth AJ; Carpenter WT; Kirkpatrick B
Schizophr Res; 2012 Dec; 142(1-3):88-92. PubMed ID: 23127378
[TBL] [Abstract][Full Text] [Related]
10. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
[TBL] [Abstract][Full Text] [Related]
11. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
[TBL] [Abstract][Full Text] [Related]
12. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
[TBL] [Abstract][Full Text] [Related]
13. Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.
DeVylder JE; Yang LH; Harkavy-Friedman JM; Azimov N; Walder DJ; Corcoran CM
Psychiatry Res; 2014 Feb; 215(2):323-8. PubMed ID: 24370335
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
[TBL] [Abstract][Full Text] [Related]
15. The brief negative symptom scale: psychometric properties.
Kirkpatrick B; Strauss GP; Nguyen L; Fischer BA; Daniel DG; Cienfuegos A; Marder SR
Schizophr Bull; 2011 Mar; 37(2):300-5. PubMed ID: 20558531
[TBL] [Abstract][Full Text] [Related]
16. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Brief Negative Symptom Scale and its association with functioning.
Ang MS; Rekhi G; Lee J
Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
[TBL] [Abstract][Full Text] [Related]
18. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
[TBL] [Abstract][Full Text] [Related]
19. Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome.
Raugh IM; James SH; Gonzalez CM; Chapman HC; Cohen AS; Kirkpatrick B; Strauss GP
Schizophr Bull; 2020 Dec; 46(6):1596-1607. PubMed ID: 32851401
[TBL] [Abstract][Full Text] [Related]
20. The brief negative symptom scale in translation: A review of psychometric properties and beyond.
Tatsumi K; Kirkpatrick B; Strauss GP; Opler M
Eur Neuropsychopharmacol; 2020 Apr; 33():36-44. PubMed ID: 32081498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
